allogeneic cell therapy

Aspen

Aspen Neuroscience levels up in-house cell therapy production

Aspen is rolling out a major upgrade to its in-house manufacturing to support a cell therapy clinical trial and its future capacity needs.

Fraiser Kansteiner Oct 2, 2024 8:15am

tree frog ribbit jump leap big and small green branch hold on

To boost production of T1D candidates, Vertex jumps to TreeFrog

Apr 24, 2024 7:25am

Type 1 diabetes

CellTrans gets FDA nod for cell therapy for Type 1 diabetes

Jun 29, 2023 10:27am